Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
183.5 GBX | +1.07% | +1.14% | +19.60% |
01:01am | DIARY-Top Economic Events to May 29 | RE |
Mar. 27 | Barclays executive denies discrimination in employee case | RE |
Sales 2024 * | 25.94B 32.71B | Sales 2025 * | 27.01B 34.06B | Capitalization | 27.36B 34.49B |
---|---|---|---|---|---|
Net income 2024 * | 4.64B 5.85B | Net income 2025 * | 5.23B 6.59B | EV / Sales 2024 * | 1.05 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
6.06
x | P/E ratio 2025 * |
4.97
x | Employees | 92,400 |
Yield 2024 * |
4.74% | Yield 2025 * |
5.52% | Free-Float | 98.54% |
Latest transcript on Barclays PLC
1 day | +1.26% | ||
1 week | +0.80% | ||
Current month | +11.46% | ||
1 month | +8.53% | ||
3 months | +19.41% | ||
6 months | +15.23% | ||
Current year | +19.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 16-02-29 | |
Angela Cross
DFI | Director of Finance/CFO | 54 | 12-12-31 |
Kirsty Everett
CMP | Compliance Officer | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Breedon
BRD | Director/Board Member | 66 | 12-10-31 |
Mohamed El-Erian
BRD | Director/Board Member | 65 | 19-12-31 |
Nigel Higgins
CHM | Chairman | 63 | 19-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.28% | 11 M€ | +0.83% | - | |
1.24% | 18 M€ | +7.01% | - | |
0.81% | 3 M€ | +9.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 183.8 | +1.25% | 3 857 013 |
24-03-27 | 181.5 | +0.41% | 85,794,040 |
24-03-26 | 180.8 | -0.39% | 128,129,900 |
24-03-25 | 181.5 | +0.38% | 82,797,100 |
24-03-22 | 180.8 | -0.57% | 34,353,480 |
Delayed Quote London S.E., March 28, 2024 at 04:20 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.20% | 34.54B | |
+17.30% | 575B | |
+12.30% | 298B | |
+3.14% | 244B | |
+17.05% | 204B | |
+8.39% | 166B | |
+1.51% | 157B | |
-2.14% | 145B | |
+1.66% | 142B | |
-14.91% | 131B |